ACS GLOBAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3 USD | -40.00% |
|
-.--% | -.--% |
| 2012 | ACS Global, Inc. Signs Agreement with Protein Genomics, Inc. for Wound Healing Cellular Therapies | CI |
| 1 day | -40.00% |
3 years
0.75
29.00
5 years
0.4529.00
10 years
0.4329.00
| Managers | Title | Age | Since |
|---|---|---|---|
| President | 61 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| President | 61 | - |
ACS Global, Inc. is engaged in evaluating opportunities for the development of new technologies in the medical and cellular therapy industries. The Company is focused on identifying the products and services for American CryoStem human cell and tissue products (hCTPs).
Sector
Business Support Services
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 171M | |
| +9.73% | 67.21B | |
| +10.81% | 18.03B | |
| +8.55% | 13.25B | |
| +19.72% | 13.16B | |
| +15.54% | 9.75B | |
| -33.72% | 5.64B | |
| -8.99% | 5.57B | |
| -2.89% | 4.88B | |
| -4.96% | 4.83B |
- Stock Market
- Equities
- AMCY Stock
